Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06512935 · ClinicalTrials.gov registry record · NA
Ventilator Pressure and Optimization of Compliance and Hemodynamics
A NA study of Bronchopulmonary Dysplasia and Extreme Prematurity, sponsored by University of Alabama at Birmingham.
- Recruiting
- Registry status
- NA
- Development phase
- 24
- Enrollment target
- 1
- Study location
NCT06512935: Recruiting NA study of Bronchopulmonary Dysplasia and Extreme Prematurity, sponsored by University of Alabama at Birmingham.
NCT06512935 is a NA study of Bronchopulmonary Dysplasia and Extreme Prematurity that is actively recruiting participants, run by University of Alabama at Birmingham. The registered enrollment target is 24 participants, below the 235-participant average among 29 other Bronchopulmonary Dysplasia trials with a reported enrollment target (90% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06512935, a NA study of Bronchopulmonary Dysplasia and Extreme Prematurity, is actively recruiting participants, sponsored by University of Alabama at Birmingham.
- RECRUITING
- Registry status
- NA
- Development phase
- 24 participants
- Enrollment target
- 1
- Study location
Study Summary
In preterm infants \< 34 weeks' gestation at birth receiving respiratory support with invasive positive pressure ventilation, the positive end-expiratory pressure (PEEP) of best compliance will increase the cardiac output and improve oxygenation. This study may emphasize using point-of-care echocardiography along with electrical impedance tomography (EIT) to optimize ventilator settings in preterm infants. Infants will be randomized to a 4-hour crossover period of increasing and decreasing PEEP in random order from baseline to determine compliance, oxygenation, and cardiac hemodynamics at each step using echocardiography (ECHO) and EIT measurements. There will be a 15-minute washout period after changes prior to data collection.
Conditions Studied
Interventions
- OTHER Increase in the PEEP followed by decrease in the PEEP
- OTHER Decrease in the PEEP followed by increase in the PEEP
Study Locations (1)
Alabama
- Univerisity of Alabama - Birmingham
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 24 participants |
| Start Date | 2025-08-01 |
| Est. Completion | 2026-06-30 |
| Phase | NA |
What NCT06512935 shows while recruiting
NCT06512935 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 24 participants, a relatively small participant target, below the 235-participant average among 29 other Bronchopulmonary Dysplasia trials with a reported enrollment target (90% lower).
The record links to 5 conditions, with Bronchopulmonary Dysplasia appearing as the primary indexed condition, and to 2 interventions - of which Increase in the PEEP followed by decrease in the PEEP is the first listed.
NCT06512935 reports a single indexed study location in Alabama.
Frequently Asked Questions
What is clinical trial NCT06512935 about?
NCT06512935 is a clinical study titled "Ventilator Pressure and Optimization of Compliance and Hemodynamics". In preterm infants \< 34 weeks' gestation at birth receiving respiratory support with invasive positive pressure ventilation, the positive end-expiratory pressure (PEEP) of best compliance will increase the cardiac output and improve oxygenation. This study may emphasize using point-of-care echocard...
What is the current status of trial NCT06512935?
This trial is currently recruiting. It is a NA study. The enrollment target is 24 participants. The study started on 2025-08-01. Estimated completion is 2026-06-30.
What conditions does trial NCT06512935 study?
This clinical trial studies the following conditions: Bronchopulmonary Dysplasia, Extreme Prematurity, Pulmonary Hypertension Due to Lung Diseases and Hypoxia, Ventilator Lung; Newborn, Ventilation Perfusion Mismatch.
What interventions are being tested in trial NCT06512935?
The interventions under investigation include: Increase in the PEEP followed by decrease in the PEEP (OTHER), Decrease in the PEEP followed by increase in the PEEP (OTHER).
Who is sponsoring clinical trial NCT06512935?
This trial is sponsored by University of Alabama at Birmingham, which has 1,160 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06512935 being conducted?
This trial has 1 study location across Alabama. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Bronchopulmonary Dysplasia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06512935's enrollment target sits among peer trials
24 27th of 29 higher than 3 of 29 other Bronchopulmonary Dysplasia trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Bronchopulmonary Dysplasia trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
The Diaphragmatic Initiated Ventilatory Assist (DIVA) Trial
RECRUITING · NA
-
Transpyloric Versus Gastric Feeding in Bronchopulmonary Dysplasia
RECRUITING · NA
-
Frequent Standardized Oral Care Using Human Milk in the Neonatal Intensive Care Unit
RECRUITING · NA
-
Effects of a Physical Therapy Intervention on Motor Delay in Infants Admitted to a Neonatal Intensive Care Unit
RECRUITING · NA
-
Gastric Feeding Versus Transpyloric Feeding in Infants with Severe Bronchopulmonary Dysplasia, a Crossover Study
RECRUITING · NA
-
Optimization of Saturation Targets And Resuscitation Trial (OptiSTART)
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02331979 · 24 participants · NA
Improving Bladder Function in SCI by Neuromodulation
- NCT03096197 · 24 participants · NA
Exoskeleton and Spinal Cord Stimulation for SCI
- NCT03223922 · 24 participants · NA
Neurocognitive Functioning With Genu-Sparing Whole Brain Radiation Therapy for Brain Metastases
- NCT03326921 · 24 participants · Phase 1
HA-1 T TCR T Cell Immunotherapy for the Treatment of Patients With Relapsed or Refractory Acute Leukemia After Donor Stem Cell Transplant
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI